FDA Inspection 1267046 — Stanford Health Care Transfusion Service

Stanford Health Care Transfusion Service — FEI 2974539

The FDA completed an inspection of Stanford Health Care Transfusion Service on March 25, 2025 in Palo Alto, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 25, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Palo Alto, CA (United States)